Two Sigma Investments, LP Invitae Corp Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.05 - $1.63 $88,581 - $137,511	84,363 Added 54.3%	239,724 $270,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $186,433 - $424,135	155,361 New	155,361 $209,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $8.41 Million - $38.2 Million	-4,428,943 Reduced 96.58%	156,728 $386,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $1.09 Million - $4.59 Million	509,509 Added 12.5%	4,585,671 $11.2 Million
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $16.5 Million - $41.1 Million	2,634,641 Added 182.77%	4,076,162 $32.5 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $21 Million - $40.9 Million	1,425,417 Added 8851.32%	1,441,521 $22 Million
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $6.25 Million - $8.64 Million	-257,281 Reduced 94.11%	16,104 $458,000
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $3.13 Million - $4.84 Million	119,890 Added 78.11%	273,385 $9.22 Million
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $4.37 Million - $7.53 Million	-132,250 Reduced 46.28%	153,495 $5.87 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $11.2 Million - $16.4 Million	285,745 New	285,745 $11.9 Million
Q1 2020 May 15, 2020	SELL	$7.64 - $27.5 $1.97 Million - $7.09 Million	-257,819 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.02 - $20.57 $3.87 Million - $5.3 Million	257,819 New	257,819 $4.16 Million
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $13.5 Million - $20.4 Million	-777,095 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $4.07 Million - $9.83 Million	381,814 Added 96.59%	777,095 $18.2 Million
Q4 2018 Feb 14, 2019	BUY	$9.26 - $16.38 $3.66 Million - $6.47 Million	395,281 New	395,281 $4.37 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

1.92M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account